Jonathan Pease, Ph.D.
|
Senior Scientist
|
| |
|
Jonathan helps oversee the research & development projects for Cedarburg Hauser Pharmaceuticals and our clients to ensure their successful outcomes. Jonathan evaluates the needs and requirements of new projects to ensure that our clients' expectations align with our capabilities in contract process research and development. He also uses his experience and expertise in API process development to assist our clients with scaling and transferring their processes from bench scale to plant production within GMP manufacturing requirements.
|
Past Experience | Education | Publications | Patents
Past Experience
|
| |
| Abbott Laboratories |
| Senior Scientist |
| |
| Types of Projects: |
- Custom Synthesis, process development and scale up work on gram to kilogram scale.
|
| |
| Abbott Biotech |
| Scientist |
| |
| Types of Projects: |
- Developed kilogram scale production route for poly lysine & poly ornithine for use as controlled release matrices in mammalian cell culture.
- Prepared a series of experimental polyamino acids for other controlled release applications.
|
Education
|
| |
| University of Iowa |
| Ph.D. Chemistry, 1981 |
| |
| Scientific Advisor: Professor Joseph Cannon |
| |
| Description of important work: |
- Synthesized resorcinol analogs of dopamine
- Conformationally restrained benzocycloheptene analogs of dopamine examined SAR requirements of central dopaminergic receptors.
|
| |
| University of Vermont |
| B.S. Chemistry, 1975 |
| |
| Scientific Advisor: Professor David Brown |
| |
| Description of important work: |
- Prepared platinum (II) cyclopropane complexes as potential anti-cancer compounds.
- Prepared key organometallic intermediates for a variety of ongoing research projects.
|
Top
Publications
Summary List of Publications
* You will find the abstracts from Jonathan's publications below along with a link to the complete text on the site which owns the copyright for the article. You may be required to have a membership for the site you are linked to in order to see the complete text.
| Synthesis of 2‘-O-Benzoyl-3-keto-6-O-propargyl-11,12-carbamoyl Erythromycin A. |
View Abstract |
| Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721. |
View Abstract |
Organic Reactions - A Book Review.
|
View Abstract |
| An EPR study of copper(II) complexes of poly(L-ornithine) and poly(L-2,4-diaminobutyric acid). |
View Abstract |
| Catechol derivatives of 6-aminobenzocycloheptene: assessment of dopaminergic effects. |
View Abstract |
| Resorcinol congeners of dopamine derived from benzocycloheptene and indan. |
View Abstract |
| Comparison of biological effects of N-alkylated congeners of .beta.-phenethylamine derived from 2-aminotetralin, 2-aminoindan, and 6-aminobenzocycloheptene. |
View Abstract |
| Benzocycloheptene Devrivatives from the Hoesch Reaction. |
View Abstract |
| Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine. |
View Abstract |
Top
| Synthesis of 2‘-O-Benzoyl-3-keto-6-O-propargyl-11,12-carbamoyl Erythromycin A. |
Organic Process Research and Development (November 15, 2002)
|
| |
| Abstract: |
| An efficient and practical synthesis of 2‘-O-benzoyl-3-keto-6-O-propargyl-11,12-carbamoyl erythromycin A (4) is described. The semisynthetic macrolide was prepared on large scale in seven steps in 38% overall isolated yield from the readily available bis(trimethylsilyloxy) ether of erythromycin A oxime ketal (5). The chemistry, which required no chromatography, involved selective hydrolysis, alkylation, and hydroxyl protection transformations. |
| |
| Detailed Listing: |
| “Synthesis of 2‘-O-Benzoyl-3-keto-6-O-propargyl-11,12-carbamoyl Erythromycin A.” F.A. Kerdesky, R. Premchandran, G.S. Wayne, S.-J. Chang, J.P. Pease, L. Bhagavatula, J.E. Lallaman, W.H. Arnold, H.E. Morton, S.A. King. Org. Proc. Res. Dev., 2002, 6 (6), pp 869–875. |
| |
| View complete text |
Summary List of Publications | Top
| Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721. |
| Tetrahedron Letters (May 28, 2001) |
| |
| Abstract: |
| A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-721 are described. |
| |
| Detailed Listing: |
| "Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721." D.J. Madar, H. Kopecka, D. Pireh, J. Pease, M.Pliushchev, R.J. Sciotti, P.E. Wiedeman, S.J. Djuric. Tetrahedron Letters, Volume 42, Issue 22, 28 May 2001, Pages 3681-3684. |
|
| View complete text |
Summary List of Publications | Top
Summary List of Publications | Top
| An EPR study of copper(II) complexes of poly(L-ornithine) and poly(L-2,4-diaminobutyric acid). |
| Macromolecules (December, 1989) |
| |
| Abstract: |
|
The interactions of poly(L-ornithine) and poly(L-2,4-diaminobutyric acid) with copper(II) in aqueous solution have been investigated by using ERP and electronic spectroscopy and potentiometric titration as a function of pH between 2 and 13. As with the copper(II)-poly(L-lysine) system, many more complexes are found to be in pH-dependent equilibrium than previous reports for these systems have indicated.
The complexes correspond to progressive replacement of the inner-sphere water molecules of the Cu(II) ion as the pH is raised, first by side-chain amines, then by deprotonated peptide nitrogens, and finally by hydroxide ligands. The length of the side chain strongly affects these equilibria. This is most noticeable in the unusual stability of the chelate of poly(L-2,4-diaminobutyric acid), where two amine and two deprotonated peptide ligands are bound to the copper even at pH values as low as 5.
This provides evidence for a chelate effect indicating that adjacent Cu(II) ligands are nitrogen atoms from amine and peptide groups of the same amino acid residue, binding to form a six-membered ring. The similarity between the ERP parameters for the three systems indicates similar ligand environments in contrast to previous suggestions that deprotonated peptide nitrogens are adjacent ligands in the copper(II)-poly(ornithine) system.
|
| |
| Detailed Listing: |
| "An EPR study of copper(II) complexes of poly(L-ornithine) and poly(L-2,4-diaminobutyric acid)." Y. Zou, F. T. Greenaway, J. P. Pease. Macromolecules, 1989, 22 (12), pp 4437–4441. |
| |
| View complete text |
Summary List of Publications | Top
| Catechol derivatives of 6-aminobenzocycloheptene: assessment of dopaminergic effects. |
| Journal of Medicinal Chemistry (July, 1984) |
| |
| Abstract: |
| The title compounds were prepared as congeners of the dopaminergically potent 2-amino-5,6-dihydroxytetralin series (“A-5,6-DTN”). None of the variously nitrogen-substituted benzocycloheptenes demonstrated any dopamine-like effects in a variety of assays. The primary amine had adrenoceptor stimulant effects. This lack of dopaminergic effect parallels the inactivity found in 6-aminobenzocycloheptenes bearing no oxygen substitutents, those bearing a single phenolic group, and those bearing a resorcinol 1,3-diphenolic substitution pattern. |
| |
| Detailed Listing: |
| "Catechol derivatives of 6-aminobenzocycloheptene: assessment of dopaminergic effects." J. G. Cannon, J. P. Pease, J. P. Long, J. R. Flynn. J. Med. Chem., 1984, 27 (7), pp 922–923. |
| |
| View complete text |
Summary List of Publications | Top
| Resorcinol congeners of dopamine derived from benzocycloheptene and indan. |
| Journal or Medicinal Chemistry (February, 1984) |
| |
| Abstract: |
| Series of N-alkylated derivatives of 2-amino-4,6-dihydroxyindan 3 and 6-amino-1,3-dihydrobenzocycloheptene 2 were prepared for pharmological testing as congeners of 2-amino-5,7-dihydroxtetralin, which elicits dopaminergic effects in a variety of assays. All of the subject compounds demonstrated a lower order of dopamine-like activity than the tetralin derivatives. Some of the subject compounds showed weak interactions with ?- and?-adrenoceptors, but the major determinant of activity seemed to be the nature of the N-alkyl substituent rather than ring size. |
| |
| Detailed Listing: |
| "Resorcinol congeners of dopamine derived from benzocycloheptene and indan." J. G. Cannon, J. P. Pease, R. L. Hamer, M. Ilhan, R. K. Bhatnagar, J. P. Long. J. Med. Chem. 1984, 27, 186. |
| |
| View complete text |
Summary List of Publications | Top
| Comparison of biological effects of N-alkylated congeners of .beta.-phenethylamine derived from 2-aminotetralin, 2-aminoindan, and 6-aminobenzocycloheptene. |
| Journal of Medicinal Chemistry (July, 1980) |
| |
| Abstract: |
| Three series of bicyclic, semirigid congeners of ?-phenethylamine have been prepared for evaluation of the effect of ring size (and of concomitant conformational variation) on biological activity in a variety of assays for adrenergic and dopaminergic actions. Pharmacological activity was associated with 2-aminotetralin and 2-aminoindan derivatives, but was not found with 6-aminobenzocycloheptene derivatives. Noteworthy is the ability of several aminotetralins and aminoindans to increase the hot-plate reaction time without eliciting dopaminergic effects. This action was not blocked by pretreatment with naloxone. |
| |
| Detailed Listing: |
| "Comparison of biological effects of N-alkylated congeners of .beta.-phenethylamine derived from 2-aminotetralin, 2-aminoindan, and 6-aminobenzocycloheptene." J. G. Cannon, J. A. Perez, J. P. Pease, J. P. Long, J. R. Flynn, D. B. Rusterholz, S. E. Dryer. J. Med. Chem., 1980, 23 (7), pp 745–749. |
| |
| View complete text |
Summary List of Publications | Top
| Benzocycloheptene Devrivatives from the Hoesch Reaction. |
| Organic Preparations and Procedures International (April, 1979) |
| |
| Abstract: |
| Not currently available. |
| |
| Detailed Listing: |
| "Benzocycloheptene Devrivatives from the Hoesch Reaction." J. G. Cannon, J. P. Pease. Organic Preparations and Procedures International, Volume 11, Issue 2 April 1979 , pages 63 - 66. |
| |
| View complete text |
Summary List of Publications | Top
| Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine. |
| European Journal of Pharmacology (April, 1979) |
| |
| Abstract: |
| A series of rigid analogs of apomorphine lacking aromatic hydroxyl substituents were evaluated for dopaminergic properties. Three compounds, N-methyl-N-propyl-2-aminotetralin (Me-Pr-2-AT), N, N-dipropyl-2-aminotetralin (Di-Pr-2-AT) and N, N-dipropyl-2-aminoindane (Di-Pr-2-AI) induced emesis in dogs, contralateral circling in unilaterally lesioned rats, and inhibited prolactin secretion. The induced circling responses, however, were attenuated by prior treatment with a-methyl-p-tyrosine methyl ester (AMPTME) and the compounds were weak inhibitors of 3H-dopamine binding in calf caudate homogenates. The posssiblity that these agents may be metabolically activated in vivo is discussed. |
| |
| Detailed Listing: |
| "Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine." D. B. Rusterholz, J. P. Long, J. R. Flynn, J. G. Cannon, T. Lee, J. P. Pease, J. A. Clemens, D. T. Wong, F. P. Bymaster. Volume 55, Issue 1, 1 April 1979, Pages 73-82. |
| |
| View complete text |
Summary List of Publications | Top
Patents
Summary List of Patents
* You will find the abstracts from Jonathan's patents below along with a link to the complete text on the appropriate office patent websites.
Process for the preparation of 6-O-propargyl erythromycin derivatives. (6,605,707)
|
View Abstract |
Top
| Process for the preparation of 6-O-propargyl erythromycin derivatives. |
| United States Patent #6,605,707 (August 12, 2003) |
| |
| Abstract: |
| Disclosed herein is a process for the preparation of erythromycin derivatives, or pharmaceutically acceptable salts thereof, which contain an optionally substituted propargyl group at the 6-O-position. |
| |
| Detailed Listing: |
| “Process for the preparation of 6-O-propargyl erythromycin derivatives.” Kerdesky; Francis A. J., Premchandran; Ramiya, Wayne; Gregory S., Chang; Sou-Jen, Pease; Jonathan P., Bhagavatula; Lakshmi, Lallaman; John E., Morton; Howard E., King; Steven A. US 6,605,707. |
| |
| View complete text |
Summary List of Patents | Top
|